- Home
- GLBS vs JAGX Comparison
GLBS vs JAGX Comparison
Compare GLBS & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLBS
- JAGX
- Stock Information
- Founded
- GLBS 2006
- JAGX 2013
- Country
- GLBS Greece
- JAGX United States
- Employees
- GLBS N/A
- JAGX N/A
- Industry
- GLBS Marine Transportation
- JAGX Biotechnology: Pharmaceutical Preparations
- Sector
- GLBS Consumer Discretionary
- JAGX Health Care
- Exchange
- GLBS Nasdaq
- JAGX Nasdaq
- Market Cap
- GLBS N/A
- JAGX 8.1M
- IPO Year
- GLBS 2007
- JAGX N/A
- Fundamental
- Price
- GLBS $1.09
- JAGX $8.70
- Analyst Decision
- GLBS
- JAGX
- Analyst Count
- GLBS 0
- JAGX 0
- Target Price
- GLBS N/A
- JAGX N/A
- AVG Volume (30 Days)
- GLBS 15.8K
- JAGX 263.8K
- Earning Date
- GLBS 06-06-2025
- JAGX 05-16-2025
- Dividend Yield
- GLBS N/A
- JAGX N/A
- EPS Growth
- GLBS N/A
- JAGX N/A
- EPS
- GLBS 0.02
- JAGX N/A
- Revenue
- GLBS $34,870,000.00
- JAGX $11,689,000.00
- Revenue This Year
- GLBS $33.39
- JAGX $38.22
- Revenue Next Year
- GLBS $22.81
- JAGX $39.96
- P/E Ratio
- GLBS $52.05
- JAGX N/A
- Revenue Growth
- GLBS 11.74
- JAGX 19.75
- 52 Week Low
- GLBS $1.00
- JAGX $4.02
- 52 Week High
- GLBS $2.40
- JAGX $502.50
- Technical
- Relative Strength Index (RSI)
- GLBS 41.10
- JAGX 47.37
- Support Level
- GLBS $1.07
- JAGX $10.41
- Resistance Level
- GLBS $1.14
- JAGX $13.20
- Average True Range (ATR)
- GLBS 0.04
- JAGX 1.85
- MACD
- GLBS 0.00
- JAGX 0.27
- Stochastic Oscillator
- GLBS 36.45
- JAGX 31.88
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.